⚖UPC-Intel
🏛️ EPO Munich

EPO T 0187/25

Court
EPO Board of Appeal 3.3.04 (Munich)
Type of action
opposition appeal
Patent
Semaglutide in cardiovascular conditions
Language
en
Claimant / applicant
  • Novo Nordisk A/S
Defendant / respondent
  • STADA Arzneimittel AG
  • Teva Pharmaceutical Industries Ltd.
  • ELKINGTON AND FIFE LLP
  • SANDOZ AG
  • Adalvo Ltd.
  • Appleyard Lees IP LLP
  • Generics (U.K.) Limited
  • Dr. Schön, Neymeyr & Partner Patentanwälte mbB

Track this case

Get an email when a new order or decision is published in EPO T 0187/25.

Decisions and documents (1)

Weekly digest

A weekly email summarising new published decisions across European patent courts.